Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Ho, Emily L ^a   Ronquillo, Rollie ^b   Altmeppen, Hermann ^c   Spudich, Serena S ^d   Price, Richard W ^e   Sinclair, Elizabeth ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LYMPHOCYTE SUBPOPULATION; MALE; MONOCYTE; NATURAL KILLER CELL; PHENOTYPE; PLEOCYTOSIS; CASE CONTROL STUDY; CYTOLOGY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; CASE-CONTROL STUDIES; CEREBROSPINAL FLUID; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED;

EID: 84879161665     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066188     Document Type: Article

References (46)

1. Spudich S, Lollo N, Liegler T, Deeks SG, Price RW, (2006) Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure. J Infect Dis 194: 1686-1696.
2. McArthur JH, Palenicek JG, Bowersox LL, (1988) Human immunodeficiency virus and the nervous system. Nurs Clin North Am 23: 823-841.
3. Marshall D, Brey R, Cahill W, Houk R, Zajac R, et al. (1988) Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 45: 954-958.
4. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, et al. (1997) Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol 42: 679-688.
5. Garcia F, Plana M, Vidal C, Cruceta A, O'Brien WA, et al. (1999) Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. Aids 13: F79-86.
6. Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, et al. (2005) Cerebrospinal fluid HIV infection and pleocytosis: Relation to systemic infection and antiretroviral treatment. BMC Infect Dis 5: 98.
7. Svenningsson A, Andersen O, Edsbagge M, Stemme S, (1995) Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J Neuroimmunol 63: 39-46.
8. Cepok S, Jacobsen M, Schock S, Omer B, Jaekel S, et al. (2001) Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 124: 2169-2176.
9. Shacklett BL, Cox CA, Wilkens DT, Karl Karlsson R, Nilsson A, et al. (2004) Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection. J Infect Dis 189: 2202-2212.
10. Maxeiner HG, Rojewski MT, Schmitt A, Tumani H, Bechter K, et al. (2009) Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders. Brain Behav Immun 23: 134-142.
11. Sinclair E, Ronquillo R, Lollo N, Deeks SG, Hunt P, et al. (2008) Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection. J Acquir Immune Defic Syndr 47: 544-552.
12. Perfetto SP, Chattopadhyay PK, Roederer M, (2004) Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 4: 648-655.
13. Noronha A, Richman DP, Arnason BG, (1985) Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations. Ann Neurol 18: 722-725.
14. Margolick JB, McArthur JC, Scott ER, McArthur JH, Cohn S, et al. (1988) Flow cytometric quantitation of T cell phenotypes in cerebrospinal fluid and peripheral blood of homosexual men with and without antibodies to human immunodeficiency virus type I. J Neuroimmunol. 20: 73-81.
15. Okuda Y, Okuda M, Apatoff BR, Posnett DN, (2005) The activation of memory CD4(+) T cells and CD8(+) T cells in patients with multiple sclerosis. J Neurol Sci 235: 11-17.
16. Scolozzi R, Boccafogli A, Tola MR, Vicentini L, Camerani A, et al. (1992) T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients. J Neurol Sci 108: 93-98.
17. Neuenburg JK, Cho TA, Nilsson A, Bredt BM, Hebert SJ, et al. (2005) T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection. J Acquir Immune Defic Syndr 39: 16-22.
18. Traugott U, (1978) T and B lymphocytes in the cerebrospinal fluid of various neurological diseases. J Neurol 219: 185-197.
19. Cepok S, von Geldern G, Grummel V, Hochgesand S, Celik H, et al. (2006) Accumulation of class switched IgD-IgM- memory B cells in the cerebrospinal fluid during neuroinflammation. J Neuroimmunol 180: 33-39.
20. Price RW, Paxinos EE, Grant RM, Drews B, Nilsson A, et al. (2001) Cerebrospinal fluid response to structured treatment interruption after virological failure. Aids 15: 1251-1259.
21. Price RW, Deeks SG, (2004) Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system. J Neurovirol 10Suppl 1: 44-51.
22. Stuve O, Marra CM, Bar-Or A, Niino M, Cravens PD, et al. (2006) Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol 63: 1383-1387.
23. de Graaf MT, Smitt PA, Luitwieler RL, van Velzen C, van den Broek PD, et al. (2011) Central memory CD4+ T cells dominate the normal cerebrospinal fluid. Cytometry B Clin Cytom 80: 43-50.
24. Ransohoff RM, Kivisakk P, Kidd G, (2003) Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3: 569-581.
25. Katz RL, Alappattu C, Glass JP, Bruner JM, (1989) Cerebrospinal fluid manifestations of the neurologic complications of human immunodeficiency virus infection. Acta Cytol 33: 233-244.
26. McArthur J, Cohen B, Farzadegan H, Cornblath D, Selnes O, et al. (1988) Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann Neurol 23(suppl): S34-S37.
27. Hollander H, Stringari S, (1987) Human immunodeficiency virus-associated meningitis: Clinical course and correlations. Am J Med 83: 813-816.
28. Morris L, Silber E, Sonnenberg P, Eintracht S, Nyoka S, et al. (1998) High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis. J Infectious Diseases 177: 473-476.
29. Gisslen M, Fuchs D, Svennerholm B, Hagberg L, (1999) Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr 21: 271-276.
30. Garcia F, Niebla G, Romeu J, Vidal C, Plana M, et al. (1999) Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication. AIDS 13: 1491-1496.
31. Neuenburg JK, Sinclair E, Nilsson A, Kreis C, Bacchetti P, et al. (2004) HIV-Producing T Cells in Cerebrospinal Fluid. J Acquir Immune Defic Syndr 37: 1237-1244.
32. Neuenburg JK, Furlan S, Bacchetti P, Price RW, Grant RM, (2005) Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. AIDS 19: 1351-1359.
33. Cepok S, von Geldern G, Nolting T, Grummel V, Srivastava R, et al. (2007) Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection. Ann Neurol 62: 458-467.
34. Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, et al. (2005) Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 128: 1667-1676.
35. Cross AH, Stark JL, Lauber J, Ramsbottom MJ, Lyons JA, (2006) Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 180: 63-70.
36. Marra CM, Tantalo LC, Maxwell CL, Dougherty K, Wood B, (2004) Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology 63: 85-88.
37. Cepok S, Zhou D, Vogel F, Rosche B, Grummel V, et al. (2003) The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis. Arch Neurol 60: 849-855.
38. Van Wielink G, McArthur JC, Moench T, Farzadegan H, McArthur JH, et al. (1990) Intrathecal synthesis of anti-HIV IgG: correlation with increasing duration of HIV-1 infection. Neurology 40: 816-819.
39. de Graaf MT, de Jongste AH, Kraan J, Boonstra JG, Sillevis Smitt PA, et al. (2011) Flow cytometric characterization of cerebrospinal fluid cells. Cytometry B Clin Cytom 80: 271-281.
40. Gregoire C, Cognet C, Chasson L, Coupet CA, Dalod M, et al. (2008) Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. Eur J Immunol 38: 2076-2084.
41. Lescure FX, Omland LH, Engsig FN, Roed C, Gerstoft J, et al. (2011) Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study. Clin Infect Dis 52: 235-243.
42. Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, et al. (2008) Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 63: 213-221.
43. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096.
44. Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, et al. (2011) Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. Aids. 25: 357-365.
45. Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, et al. (2011) CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. Aids. 25: 1747-1751.
46. Spudich S, Gonzalez-Scarano F, (2012) HIV-1-Related Central Nervous System Disease: Current Issues in Pathogenesis, Diagnosis, and Treatment. Cold Spring Harbor perspectives in medicine. 2: a007120.